Innate Pharma SA (IPHA) Form 6-K — Aug 14, 2026

$IPHAForm 6-KFiled Aug 14, 2026, 6:00 AM ET0001628280-26-056913Original filing

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) announced it will hold a conference call and webcast on Friday, August 14, 2026 at 2:00 p.m. CEST / 8:00 a.m. EDT, with a replay available on the company website. Scheduled participants include Chief Executive Officer Jonathan Dickinson, Chief Operating Officer Yannis Morel, and Chief Financial Officer Frédéric Lombard.

AI analysis

Red flags1 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.